Dr. Vij on Tumor Bank for Multiple Myeloma at Siteman Cancer Center

Video

In Partnership With:

Ravi Vij, MD, associate professor, medicine, Division of Oncology, Section of Bone Marrow Transplant, Siteman Cancer Center, discusses the institution's tumor banking initiative for next-generation sequencing in multiple myeloma.

Ravi Vij, MD, associate professor, medicine, Division of Oncology, Section of Bone Marrow Transplant, Siteman Cancer Center, discusses the institution's tumor banking initiative for next-generation sequencing in multiple myeloma.

Initially, the tumor banking initiative at Siteman Cancer Center was set up to research acute myeloid leukemia and myelodysplastic syndrome, Vij says. The tumor tissues were eventually used for next-generation sequencing, which has helped with the genomics of these diseases to help develop targeted therapies.

The tumor bank is being pulled from again, Vij explains, to research next-generation sequencing in multiple myeloma. Coupled with new technologies, it will help to better define the mutational spectrum of patients with multiple myeloma. These tissues are also to be used in collaboration with other institutions and companies to help improve outcomes of these patients.

Additional tumor bank initiatives are taking place at other institutions for other malignancies, Vij says.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD